Randal W. Scott Bridge Bio Pharma, Inc. (BBIO) insider trading activity

BBIO Quotes by TradingView

Randal W. Scott is Director of BridgeBio Pharma, Inc.. Currently has a direct ownership of 11,589 shares of BBIO, which is worth approximately $769,393. The most recent transaction as insider was on Nov 17, 2025, when has been sold 10,000 shares (Common Stock) at a price of $66.57 per share, resulting in proceeds of $665,699. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 11.6K
0% 3M change
44.81% 12M change
Total Value Held $769,393

Randal W. Scott Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 17 2025
SELL
Open market or private sale
$665,699 $66.57 p/Share
10,000 Reduced 46.32%
11,589 Common Stock
Nov 17 2025
BUY
Exercise of conversion of derivative security
$167,500 $16.75 p/Share
10,000 Added 31.66%
21,589 Common Stock
Jun 20 2025
BUY
Grant, award, or other acquisition
-
6,589 Added 36.25%
11,589 Common Stock
Feb 17 2021
BUY
Open market or private purchase
$1,000,000 $62.5 p/Share
16,000 Added 43.24%
21,000 Common Stock

Also insider at

TLIS
Talis Biomedical Corp Healthcare
Director
NVTA
Invitae Corp Healthcare
Director
RWS

Randal W. Scott

Director
San Francisco, CA

Track Institutional and Insider Activities on BBIO

Follow BridgeBio Pharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BBIO shares.

Notify only if

Insider Trading

Get notified when an Bridge Bio Pharma, Inc. insider buys or sells BBIO shares.

Notify only if

News

Receive news related to BridgeBio Pharma, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BBIO